Endocrinology

Top Story

Experts list year’s top findings in menopause, women’s health

October 20, 2017

PHILADELPHIA — At the Annual Meeting of the North American Menopause Society, leaders in the field presented recent standout articles in the field of menopause and women’s health research.

The topics ranged from new treatments, updates on the Women’s Health Initiative data and potential new therapeutic options.

In the Journals PlusPerspective

SCALE: Liraglutide increases health-related quality of life in obesity, prediabetes

October 20, 2017
Adults with obesity and prediabetes showed 3-year improvements in health-related quality of life and weight loss with once-daily subcutaneous liraglutide compared with…
In the Journals Plus

Long-acting pasireotide safe, effective for recurrent Cushing’s disease

October 20, 2017
In patients with persistent or recurring Cushing’s disease after surgery, monthly pasireotide was safe and effective, leading to normal urinary free cortisol…
In the Journals Plus

Brain glucose levels diminished in obesity, type 2 diabetes during hyperglycemia

October 20, 2017
Adults with obesity or poorly controlled type 2 diabetes have decreased intracerebral glucose levels that can lead to adverse neurocognitive consequences, according to…
In the Journals PlusPerspective

Commercial weight-management program effective for diabetes prevention

October 20, 2017
Adults at high risk for type 2 diabetes may successfully reduce that risk — and their body weight — when participating in a diabetes prevention program…
More Headlines »
CME

Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen

A preponderance of data shows that low-density lipoprotein cholesterol (LDL-C) plays a causal role in atherosclerotic…
More »
Video
Meeting News

VIDEO: Guidelines needed for treatment of genitourinary syndrome of menopause in breast cancer survivors

October 12, 2017
More »
Resource Centers

CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement